Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024
J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;
Rev Gastroenterol Mex. 2025;90:77-110
Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown are associated with the development of gastrointestinal symptoms
F. Higuera-de-la-Tijera; A. Servín-Caamaño; F. Lajud-Barquín; A. Tovar-Aguilar;
Rev Gastroenterol Mex. 2024;89:481-90
Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one
R. Maslennikov; V. Ivashkin; A. Ufimtseva; E. Poluektova;
Rev Gastroenterol Mex. 2022;87:59-62